News - MedTech

ICO fines bankrupt 23andMe for ‘profoundly damaging breach’

The Information Commissioner’s Office (ICO) has fined genetic testing company 23andMe £2.31m. ...

MedTech developing therapies for heart failure raises extra £5m

Cardiff-based MedTech Ceryx Medical has closed a fresh £5m funding round, bringing the company’s ...

Female-founded virtual cancer clinic raises £3m funding round

A female-led virtual cancer clinic has now raised a total of £7.7m funding after closing a new £3m...

Royal College of Art spinout making IV drips safer raises £300k

Chesham-based Flomark Ltd, has secured £300,000 in funding as it looks to accelerate the developmen...

Manchester spinout raises £1.8m to treat chronic diseases

Apini, a small molecule drug development programme being advanced by Syncona’s accelerator Slingsh...

MedTech given £860k Innovate UK grant to detect colorectal cancer

A biomarker discovery and diagnostics startup has been awarded £860,000 in funding from Innovate UK...

BioTech acquires Toronto-based Awakn

Clinical-stage BioTech Solvonis has acquired Toronto-based Awakn, expanding its research and develop...

BioTech CellCentric announces new chief financial officer

Cambridge-based BioTech CellCentric has appointed Celia Economides as its new chief financial office...

BioNTech unveils plan to invest £1bn in the UK

World-leading biopharmaceutical company BioNTech has announced a planned £1bn investment into the U...

AstraZeneca agrees £750m deal for EsoBiotec

AstraZeneca has agreed a deal to acquire EsoBiotec for up to £750m. The acquisition includes the...

CellCentric raises £90m to prevent cancer deaths

Cancer-fighting MedTech CellCentric has raised £90m in fresh funding. The Series C round will su...

Envoke raises further £1m after almost doubling ARR in last year

A UK company whose simulation software enables medical staff to train to use laboratory equipment an...

Subscribe to our newsletter

    This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.